Skip to main content
Main navigation
Home
About pCPA
Who We Are
Governance
FAQs
Negotiations
Recent Updates
Forms and Publications
Brand Name Drugs
Negotiations Status
Negotiation Process
Generic Drugs
Biologics/Biosimilars
Contact Us
EN
FR
Crysvita (burosumab)
pCPA File Number:
21235
Negotiation Status:
Active Negotiation
Indication(s):
X-Linked Hypophosphatemia
Sponsor/Manufacturer:
Ultragenyx Canada Inc.
CADTH Project Number:
SR0602-000
pCPA Engagement Letter Issued:
2020-10-09
Negotiation Process Concluded:
Not Applicable